Kymera Therapeutics Inc
KYMR
$125.31-1.05%
Delayed · as of Aug 26, 2026, 1:21 PM ET
Mkt cap
$7.39B
EV/Sales
179.5
P/E ratio
N/A
FY2025 Revenue
$39.21M
EPS (TTM)
$-3.25
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-794.04%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
Latest reported KYMR revenue for 2025-12-31 was $39.2M. Net income was -$311.4M. Revenue was down 16.7% from 2024-12-31 to 2025-12-31. KYMR currently screens at market cap $7.39B.
Use this KYMR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full KYMR income, balance, and cash tables.
Kymera Therapeutics Inc (KYMR) is a biotechnology company in the Healthcare sector.
Latest cached Kymera Therapeutics Inc (KYMR) revenue for Dec 31, 2025 was $39.2M. Net income was -$311.4M. Statements: https://lician.com/financials/kymr
Kymera Therapeutics Inc (KYMR) market capitalization is $7.39B on the latest cached snapshot.
Kymera Therapeutics Inc (KYMR) cached previous close $126.64; day range $123.54 – $126.32; volume 227,795. Session quote: https://lician.com/quote/kymr
Kymera Therapeutics Inc (KYMR) latest cached earnings event is "KYMR earnings" on Aug 10, 2026. Earnings calendar: https://lician.com/earnings
The latest cached KYMR filing is 8-K · Aug 5, 2026. Filings: https://lician.com/sec/kymr